Prism Pharmaceuticals

About:

Prism Pharmaceuticals is an acute care pharmaceutical company engaged in developing and commercializing cardiovascular injectable products.

Website: http://www.prismpharma.com

Top Investors: Essex Woodlands Healthcare Partners, Stephens Group, Innovation Network Corporation of Japan, Paul Capital Partners

Description:

Prism Pharmaceuticals, Inc., an acute care pharmaceutical company, engages in developing and commercializing cardiovascular injectable products in the United States. Its products include NEXTERONE, an anti arrhythmic agent in the form of injectable amiodarone; and PM103, an intravenous formulation of clopidogrel bisulfate. The company was founded in 2004 and is based in King of Prussia, Pennsylvania.